The hormone estrogen regulates binge drinking in females, causing them to “pregame” – consume large quantities of alcohol in the first 30 minutes after it’s offered, according to a preclinical study led by scientists at Weill Cornell Medicine.
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
Inhibiting an immune signaling protein may help preserve the protective layer surrounding nerve fibers in the brain during both Alzheimer’s disease and ordinary aging, a new study suggests.
John August, program director of healthcare labor relations at Cornell University’s School of Industrial and Labor Relations, said he expects the healthcare consolidation trend to continue.
A new protocol can detect and remove fake data created by bots and humans attempting to enroll in online research studies, in order to prevent biased results and unwarranted payments to bad actors – the first such protocol specifically designed for data collected in rural communities.
The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.
The Cornell Atkinson Center for Sustainability’s 15th-anniversary conference addressed past successes and future efforts to support climate and sustainability.
Through its new Public Health Essentials online certificate program, Cornell seeks to help leaders proactively address today’s global health challenges.